NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has scheduled its annual general meeting for Tuesday, June 1, 2010 at 1000 EDT. The meeting will be hosted at Nasdaq OMX headquarters in New York City. Formal invitations will be mailed over the coming few weeks.
